Your session is about to expire
← Back to Search
Reminder for Immunization Programs
N/A
Waitlist Available
Led By Amir Goren, PhD
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Parents (or contact on record) of children aged 5, 8, 11, 14, or 17 months
No WCC visits scheduled 30 days after the child's monthly birthday (for 5 month-olds) or 60 days (for all other ages) ahead of their due date for a WCC (i.e., month 6, 9, 12, 15, or 18)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 61-150 days from the email send date
Awards & highlights
Study Summary
This trial will test whether email reminders for well-child checkups increase attendance beyond what occurs without reminders.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 61-150 days from the email send date
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~61-150 days from the email send date
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
WCC visit scheduled
Secondary outcome measures
Immunization status
WCC visit made
Other outcome measures
Emails opened
Follow-up WCC visit scheduled
Hepatitis A immunization status
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ReminderExperimental Treatment1 Intervention
Reminder email with contact information to set an appointment will be sent 12 weeks before the appointment.
Group II: No ContactActive Control1 Intervention
No reminder sent
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Reminder
2022
N/A
~311170
Find a Location
Who is running the clinical trial?
Geisinger ClinicLead Sponsor
147 Previous Clinical Trials
1,876,607 Total Patients Enrolled
Amir Goren, PhDPrincipal InvestigatorProgram Director, Behavioral Insights Team
19 Previous Clinical Trials
522,235 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger